126 related articles for article (PubMed ID: 2899583)
1. Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third generation cephalosporins.
Nicolle LE
J Hosp Infect; 1988 May; 11(4):321-7. PubMed ID: 2899583
[TBL] [Abstract][Full Text] [Related]
2. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
Jacobson KL; Cohen SH; Inciardi JF; King JH; Lippert WE; Iglesias T; VanCouwenberghe CJ
Clin Infect Dis; 1995 Nov; 21(5):1107-13. PubMed ID: 8589129
[TBL] [Abstract][Full Text] [Related]
3. Clinical consequences of development of resistance to third generation cephalosporins.
Follath F; Costa E; Thommen A; Frei R; Burdeska A; Meyer J
Eur J Clin Microbiol; 1987 Aug; 6(4):446-50. PubMed ID: 3117534
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Int J Antimicrob Agents; 2000 Jul; 15(2):111-8. PubMed ID: 10854806
[TBL] [Abstract][Full Text] [Related]
5. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. III].
Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
Jpn J Antibiot; 1985 Jun; 38(6):1603-18. PubMed ID: 3930806
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
7. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Babálová M; Krălíková K; Krcméry V; Kubonová K
Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362
[TBL] [Abstract][Full Text] [Related]
8. Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy.
Weinstein RA
Infect Control; 1986 Feb; 7(2 Suppl):120-3. PubMed ID: 3633889
[No Abstract] [Full Text] [Related]
9. [Resistance to cephalosporin in hospital strains of the KES group].
Granatiero F; Grandis C; Malandrino M; Oneglio R
G Batteriol Virol Immunol; 1989; 82(1-12):141-51. PubMed ID: 2490396
[TBL] [Abstract][Full Text] [Related]
10. Importance of Reviewing Antibiotic Courses by 48 Hours: Risk Factors for Third-Generation Cephalosporin Resistance Among AmpC Harboring Organisms in Urine and Respiratory Cultures.
Stultz JS; Bice T; Johnstone K; Stuart CM; Shelton CM; Arnold SR; Bagga B; Lee KR
Pediatr Infect Dis J; 2021 May; 40(5):440-445. PubMed ID: 33264210
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Berche P; Gaillard JL
Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
[TBL] [Abstract][Full Text] [Related]
13. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
Washington JA II
J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
Jean SS; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Antimicrob Chemother; 2002 Jan; 49(1):69-76. PubMed ID: 11751769
[TBL] [Abstract][Full Text] [Related]
15. Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
Toye BW; Scriver SR; Low DE
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():81-6. PubMed ID: 8150770
[TBL] [Abstract][Full Text] [Related]
16. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
Papanicolaou GA; Medeiros AA
Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
18. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
Rosenthal SL; Freundlich LF; Quraishi MA
Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
[TBL] [Abstract][Full Text] [Related]
20. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.
Legrand P; Fournier G; Buré A; Jarlier V; Nicolas MH; Decré D; Duval J; Philippon A
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):527-9. PubMed ID: 2504594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
